Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape

Published:2016-11 Issue:11 Volume:27 Page:2004-2016
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Olaussen K.A.,Postel-Vinay S.

Funder

‘Etablissement Public Chancellerie des Universités de Paris (Legs Poix)’

Fondation de France

Fondation ARC pour la Recherche sur le Cancer

Agence National de la Recherche

Institut National du Cancer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/11/2004/7935015/mdw321.pdf

Reference126 articles.

1. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches;Shea;Ther Adv Respir Dis,2016

2. Nivolumab versus Docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

3. Nivolumab in NSCLC: latest evidence and clinical potential;Sundar;Ther Adv Med Oncol,2015

4. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer;Burdett;Cochrane Database Syst Rev,2015

5. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?;Malvezzi;Ann Oncol,2015

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRE1α‐XBP1s axis regulates SREBP1‐dependent MRP1 expression to promote chemoresistance in non‐small cell lung cancer cells;Thoracic Cancer;2024-09-08

2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

3. Mesoporous Graphene Oxide Nanocomposite Effective for Combined Chemo/Photo Therapy Against Non-Small Cell Lung Cancer;International Journal of Nanomedicine;2024-07

4. Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways;Diseases;2024-05-06

5. Exploring effective biomarkers and potential immune related gene in small cell lung cancer;Scientific Reports;2024-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3